Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $205.04 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Acella Pharmaceuticals, LLC | $162.44 | 10 | $0 (2024) |
| Novo Nordisk Inc | $42.60 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.64 | 1 | Acella Pharmaceuticals, LLC ($16.64) |
| 2023 | $41.02 | 1 | Acella Pharmaceuticals, LLC ($41.02) |
| 2022 | $70.10 | 3 | Novo Nordisk Inc ($42.60) |
| 2020 | $13.69 | 1 | Acella Pharmaceuticals, LLC ($13.69) |
| 2019 | $41.01 | 3 | Acella Pharmaceuticals, LLC ($41.01) |
| 2018 | $22.58 | 2 | Acella Pharmaceuticals, LLC ($22.58) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/10/2024 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Hyperthyroidism | ||||||
| 05/24/2023 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $41.02 | General |
| Category: Hyperthyroidism | ||||||
| 10/28/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $42.60 | General |
| Category: Diabetes | ||||||
| 07/27/2022 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: Hyperthyroidism | ||||||
| 03/02/2022 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Hyperthyroidism | ||||||
| 02/12/2020 | Acella Pharmaceuticals, LLC | NP Thyroid (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Hyperthyroidism | ||||||
| 12/11/2019 | Acella Pharmaceuticals, LLC | NP Thyroid (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Hyperthyroidism | ||||||
| 11/26/2019 | Acella Pharmaceuticals, LLC | NP Thyroid (Drug) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: Hyperthyroidism | ||||||
| 06/27/2019 | Acella Pharmaceuticals, LLC | NP Thyroid (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: Hyperthyroidism | ||||||
| 12/10/2018 | Acella Pharmaceuticals, LLC | NP Thyroid (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: Hyperthyroidism | ||||||
| 11/01/2018 | Acella Pharmaceuticals, LLC | NP Thyroid (Drug) | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: Hyperthyroidism | ||||||
About Dr. James Ziobron, D.O
Dr. James Ziobron, D.O is a Family Medicine healthcare provider based in Bruce, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1407901267.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Ziobron, D.O has received a total of $205.04 in payments from pharmaceutical and medical device companies, with $16.64 received in 2024. These payments were reported across 11 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($205.04).
Practice Information
- Specialty Family Medicine
- Location Bruce, MI
- Active Since 01/24/2007
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1407901267
Products in Payments
- NP Thyroid 60 (Drug) $85.16
- NP Thyroid (Drug) $77.28
- Rybelsus (Drug) $42.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.